Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
Novo Nordisk gears up for December Ozempic launch in India, sources say- Ifo: Job cuts in Germany slowing but not enough for a turnaround
- 15 skywatching events you won't want to miss in 2026
- Bavarian leader questions Germany's Eurovision participation
- Major Scottish gangland figure Steven Lyons arrested in Bali
- A Manual for Pick Great Lawful Discussion Administrations For New businesses In 2024
- The Specialty of Compromise: Examples from Reality
- Birutė Galdikas: The last of the ‘angels’ in primatology’s most extraordinary chapter
- Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
